These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6698980)

  • 1. Predictions of the secondary structure of antithrombin III and the location of the heparin-binding site.
    Villanueva GB
    J Biol Chem; 1984 Feb; 259(4):2531-6. PubMed ID: 6698980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refolding properties of antithrombin III. Mechanism of binding to heparin.
    Villanueva GB; Allen N
    J Biol Chem; 1983 Nov; 258(22):14048-53. PubMed ID: 6643466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the domain structure of antithrombin III. Tentative localization of the heparin binding region using 1H NMR spectroscopy.
    Gettins P; Wooten EW
    Biochemistry; 1987 Jul; 26(14):4403-8. PubMed ID: 3663595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS; Chang JY
    Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.
    Blackburn MN; Smith RL; Carson J; Sibley CC
    J Biol Chem; 1984 Jan; 259(2):939-41. PubMed ID: 6693405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the range in binding-site densities of rat skin heparin chains with high binding affinities for antithrombin.
    Horner AA; Kusche M; Lindahl U; Peterson CB
    Biochem J; 1988 Apr; 251(1):141-5. PubMed ID: 3390150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the antithrombin III heparin binding site.
    Ersdal-Badju E; Lu A; Zuo Y; Picard V; Bock SC
    J Biol Chem; 1997 Aug; 272(31):19393-400. PubMed ID: 9235938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of heparin to human antithrombin III activates selective chemical modification at lysine 236. Lys-107, Lys-125, and Lys-136 are situated within the heparin-binding site of antithrombin III.
    Chang JY
    J Biol Chem; 1989 Feb; 264(6):3111-5. PubMed ID: 2492530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energetics of hydrogen bond switch, residue burial and cavity analysis reveals molecular basis of improved heparin binding to antithrombin.
    Singh P; Singh K; Jairajpuri MA
    J Biomol Struct Dyn; 2011 Oct; 29(2):339-50. PubMed ID: 21875153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin binding site, conformational change, and activation of antithrombin.
    Evans DL; Marshall CJ; Christey PB; Carrell RW
    Biochemistry; 1992 Dec; 31(50):12629-42. PubMed ID: 1366018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridoxylation of essential lysines in the heparin-binding site of antithrombin III.
    Pecon JM; Blackburn MN
    J Biol Chem; 1984 Jan; 259(2):935-8. PubMed ID: 6420409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of five sulfated hexasaccharides prepared from porcine intestinal heparin using bacterial heparinase. Structural variants with apparent biosynthetic precursor-product relationships for the antithrombin III-binding site.
    Tsuda H; Yamada S; Yamane Y; Yoshida K; Hopwood JJ; Sugahara K
    J Biol Chem; 1996 May; 271(18):10495-502. PubMed ID: 8631846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of arginine 132 and lysine 133 in heparin binding to and activation of antithrombin.
    Meagher JL; Huntington JA; Fan B; Gettins PG
    J Biol Chem; 1996 Nov; 271(46):29353-8. PubMed ID: 8910598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heparin binding site of human antithrombin III. Selective chemical modification at Lys114, Lys125, and Lys287 impairs its heparin cofactor activity.
    Liu CS; Chang JY
    J Biol Chem; 1987 Dec; 262(36):17356-61. PubMed ID: 3121595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III.
    Pimenta DC; Nantes IL; de Souza ES; Le Bonniec B; Ito AS; Tersariol IL; Oliveira V; Juliano MA; Juliano L
    Biochem J; 2002 Sep; 366(Pt 2):435-46. PubMed ID: 12000310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
    Desai UR; Petitou M; Björk I; Olson ST
    Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin binding domain of antithrombin III: characterization using a synthetic peptide directed polyclonal antibody.
    Smith JW; Dey N; Knauer DJ
    Biochemistry; 1990 Sep; 29(38):8950-7. PubMed ID: 2271570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational changes accompanying the binding of antithrombin III to thrombin.
    Villanueva G; Danishefsky I
    Biochemistry; 1979 Mar; 18(5):810-7. PubMed ID: 420817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin binding domain peptides of antithrombin III: analysis by isothermal titration calorimetry and circular dichroism spectroscopy.
    Tyler-Cross R; Sobel M; Marques D; Harris RB
    Protein Sci; 1994 Apr; 3(4):620-7. PubMed ID: 8003980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A heparin binding site in antithrombin III. Identification, purification, and amino acid sequence.
    Smith JW; Knauer DJ
    J Biol Chem; 1987 Sep; 262(25):11964-72. PubMed ID: 3305499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.